New information may help speed development of a vaccine or treatment for dengue fever.

Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes.

New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly.

Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines.

After recent efforts to develop a vaccine to protect against AIDS proved ineffective, the National Institutes of Health announced a change in research direction; and it\'s one that will involve the lab of James Crowe, M.D., professor of Pediatrics, Microbiology and Immunology at the Monroe Carell Jr. Children\'s Hospital at Vanderbilt.

James Crowe, M.D., is a Vanderbilt professor of pediatrics, microbiology and immunology. Crowe discussed the concerns associated with possible influenza pandemic.